NCT06434675

Brief Summary

A retrospective study was conducted on 343 patients. CT PNS and head of the patients were evaluated for variants of nasal septum and nasal cavity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
343

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 19, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 30, 2024

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

May 19, 2024

Last Update Submit

May 23, 2024

Conditions

Keywords

Nasal SeptumNasal CavityTurbinate

Outcome Measures

Primary Outcomes (2)

  • Prevalence of variants of Nasal septum

    Prevalence of deviated nasal septum will be calculated. Among those with nasal septum deviation, frequency of deviation to right, left and S shaped nasal septum will be evaluated. Nasal septal deviation angle will be measured and grading will be done.

    6 months

  • Prevalence of variants of nasal cavity

    Prevalence of variants of nasal cavities like hypertrophied turbinate, paradoxical turbinate, concha bullosa, lamellar concha will be obtained.

    6 months

Study Arms (1)

Polyps

Patients evaluated for nasal polyps

Other: No intervention done

Interventions

No intervention done

Polyps

Eligibility Criteria

Age13 Years - 91 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient of age 13 years and more undergoing NCCT PNS and Head for chronic rhinosinusitis , headache and vertigo

You may qualify if:

  • )Patients undergoing NCCT PNS and Head for chronic rhinosinusitis, headache and vertigo

You may not qualify if:

  • Patient less than 13 years age
  • Patients with recent trauma
  • Patient with large mass/ extensive polyposis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prajwal Dahal

Kathmandu, Bagmati, Nepal, Nepal

Location

Study Officials

  • PRAJWAL DAHAL

    Grande International Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 19, 2024

First Posted

May 30, 2024

Study Start

September 15, 2023

Primary Completion

May 1, 2024

Study Completion

May 5, 2024

Last Updated

May 30, 2024

Record last verified: 2024-05

Locations